Tacoma, WANCT07727538Now EnrollingIRB Ready

Familial Chylomicronemia Syndrome Clinical Trial in Tacoma, WA

Access cutting-edge familial chylomicronemia syndrome treatment through this phase 3 clinical trial at a research site in Tacoma. Study-provided care at no cost to qualified participants.

Sponsored by Ionis Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this Tacoma location

Preparing your pre-screening questions…

Expert Care in Tacoma

Access familial chylomicronemia syndrome specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related familial chylomicronemia syndrome treatment provided free

Apply for This Tacoma Location

Check if you qualify for this familial chylomicronemia syndrome clinical trial in Tacoma, WA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tacoma

    Convenient for WA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tacoma site if eligible
  4. 4Begin participation

About This Familial Chylomicronemia Syndrome Study in Tacoma

The primary purpose of the study is to evaluate the efficacy of olezarsen administered by subcutaneous injection to pediatric participants with FCS.

Sponsor: Ionis Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Parental or legally authorized representative consent must be obtained, and the participants must provide age-appropriate or cognition-appropriate assent, as determined by the Investigator. The parent or legal guardian must be able to understand and comply with the study visit schedule and all other study procedures.
Must be able to comply with all study procedures.
Age 12 to less than 18 years at the time of informed consent/assent (Cohort 1); age 2 to less than 12 years at time of informed consent/assent (Cohort 2).
Willing to fast for at least 10 hours before visits requiring fasted blood sampling.
A diagnosis of Familial Chylomicronemia Syndrome (type 1 Hyperlipoproteinemia) by documentation of confirmed homozygote, compound heterozygote or double heterozygote for loss-of-function mutations in type 1-causing genes.
Fasting TGs ≥880 mg/dL at screening. If fasting TG is \< 880 mg/dL, up to two additional tests may be performed during the screening period with any single test used to qualify. Key

Exclusion Criteria

Diabetes mellitus with any of the following:
Newly diagnosed within 12 weeks prior to screening or during the screening period.
Hemoglobin A1c (HbA1c) ≥9.5% at screening.
Change in basal insulin regimen \>20% within 3 months prior to screening or during the screening period.
For participants with type 1 diabetes: episode of diabetic ketoacidosis, or ≥3 episodes of severe hypoglycemia within 6 months prior to screening or during the screening period.
History of bleeding, diathesis, or coagulopathy.
Major surgery within 3 months of screening.
Plasma apheresis within 4 weeks prior to screening or planned during the study.
Treatment with another investigational drug, biological agent, or device within one month of screening, or 5 half-lives of investigational agent, whichever is longer.
Active pancreatitis within 4 weeks prior to screening or during the screening period.
Malignancy diagnosed or treated within 5 years prior to screening or during the screening period. Note: Other protocol-specified inclusion/exclusion criteria may apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tacoma?

Yes, this clinical trial (NCT07727538) has an active research site in Tacoma, WA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Familial Chylomicronemia Syndrome Treatment Options in Tacoma, WA

If you're searching for familial chylomicronemia syndrome treatment options in Tacoma, WA, this clinical trial (NCT07727538) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tacoma research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced familial chylomicronemia syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all familial chylomicronemia syndrome clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Tacoma, WA

See all heart attack clinical trials recruiting in Tacoma — not just this study.

Browse Heart Attack Trials in Tacoma →

Browse More Trials by Condition

Heart Attack TrialsInterstitial Cystitis TrialsMyocardial Infarction TrialsFanconi Anemia TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Tacoma?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tacoma, WA